Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to $8.2 million.

  • Usana Health Sciences' Change in Inventory rose 127846.82% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.5 million, marking a year-over-year increase of 102072.54%. This contributed to the annual value of $2.1 million for FY2024, which is 19001.27% up from last year.
  • As of Q3 2025, Usana Health Sciences' Change in Inventory stood at $8.2 million, which was up 127846.82% from $8.1 million recorded in Q2 2025.
  • Usana Health Sciences' Change in Inventory's 5-year high stood at $8.2 million during Q3 2025, with a 5-year trough of -$8.5 million in Q3 2022.
  • Its 5-year average for Change in Inventory is $562411.8, with a median of -$48000.0 in 2022.
  • In the last 5 years, Usana Health Sciences' Change in Inventory crashed by 12663.02% in 2022 and then soared by 220897.44% in 2024.
  • Quarter analysis of 5 years shows Usana Health Sciences' Change in Inventory stood at -$1.4 million in 2021, then fell by 11.7% to -$1.6 million in 2022, then crashed by 32.2% to -$2.1 million in 2023, then increased by 18.52% to -$1.7 million in 2024, then surged by 586.58% to $8.2 million in 2025.
  • Its last three reported values are $8.2 million in Q3 2025, $8.1 million for Q2 2025, and $4.9 million during Q1 2025.